Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Naredi

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Research|December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineP Naredi, D D Heath, R E Enns, et al.
The European Journal of Surgery = Acta Chirurgica|February 1, 1994
Whole body energy expenditure protein breakdown and polyamine excretion during high dose treatment with interleukin-2 and interferon-alphaP Naredi, L Hafström, H Zachrisson, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancerM Oman, S Lundqvist, B Gustavsson, et al.
Langenbeck'S Archives of Surgery|March 20, 2022
C-reactive protein identifies patients at risk of postpancreatectomy hemorrhageC Vilhav, J B Fagman, E Holmberg, et al.
The Journal of Clinical Investigation|March 1, 1995
Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cellsP Naredi, D D Heath, R E Enns, et al.
Acta Oncologica (Stockholm, Sweden)|September 22, 1998
Histamine and cytokine therapyK Hellstrand, S Hermodsson, P Naredi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 16, 2001
Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IVM Oman, P J Blind, P Naredi, et al.
British Journal of Cancer|June 4, 2009
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancerD Ohlund, C Lundin, B Ardnor, et al.
Hepato-Gastroenterology|July 9, 2004
133Xe clearance estimates the effect of vasopressin on peritoneal blood flow in ratsM Oman, J Tölli, P J Blind, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 1998
Immunohistochemical analysis of the distribution of the human ATPase (hASNA-I) in normal tissues and its overexpression in breast adenomas and carcinomasB Kurdi-Haidar, D Heath, P Naredi, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Research|December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineP Naredi, D D Heath, R E Enns, et al.
The European Journal of Surgery = Acta Chirurgica|February 1, 1994
Whole body energy expenditure protein breakdown and polyamine excretion during high dose treatment with interleukin-2 and interferon-alphaP Naredi, L Hafström, H Zachrisson, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancerM Oman, S Lundqvist, B Gustavsson, et al.
Langenbeck'S Archives of Surgery|March 20, 2022
C-reactive protein identifies patients at risk of postpancreatectomy hemorrhageC Vilhav, J B Fagman, E Holmberg, et al.
The Journal of Clinical Investigation|March 1, 1995
Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cellsP Naredi, D D Heath, R E Enns, et al.
Acta Oncologica (Stockholm, Sweden)|September 22, 1998
Histamine and cytokine therapyK Hellstrand, S Hermodsson, P Naredi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 16, 2001
Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IVM Oman, P J Blind, P Naredi, et al.
British Journal of Cancer|June 4, 2009
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancerD Ohlund, C Lundin, B Ardnor, et al.
Hepato-Gastroenterology|July 9, 2004
133Xe clearance estimates the effect of vasopressin on peritoneal blood flow in ratsM Oman, J Tölli, P J Blind, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 1998
Immunohistochemical analysis of the distribution of the human ATPase (hASNA-I) in normal tissues and its overexpression in breast adenomas and carcinomasB Kurdi-Haidar, D Heath, P Naredi, et al.
Pageof 6